Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 718 of 767

Advanced search

🇨🇦Oct 24, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

Innovative Medicines Canada responds to release of Patented Medicine Prices Review Board’s (PMPRB) final Guidelines

Innovative Medicines CanadaOriginal source

🇺🇸Oct 1, 2020Industrydyne-tx.comTier 1 · Company source

Our Focus - Dyne Therapeutics

Dyne TherapeuticsOriginal source

🇺🇰Sep 29, 2020Industryorchard-tx.comTier 1 · Company source

HSC Gene Therapy for Neurological Conditions

Orchard TherapeuticsOriginal source

🌍Sep 10, 2020Industryomniab.comTier 1 · Company source

Ligand Expands OmniAb Antibody Discovery Platform Through the Acquisitions of xCella Biosciences and Taurus Biosciences

OmniAbOriginal source

🌍Sep 4, 2020Industryproqr.comTier 1 · Company source

H.C. Wainwright 22nd Annual Global Investment Conference

ProQROriginal source

🌍Sep 4, 2020Industryproqr.comTier 1 · Company source

Citi's 15th Annual BioPharma Virtual Conference

ProQROriginal source

🌍Sep 4, 2020Industryproqr.comTier 1 · Company source

Chardan Virtual 4th Annual Genetic Medicines Conference

ProQROriginal source

🇺🇰Sep 3, 2020Industryorchard-tx.comTier 1 · Company source

Gene therapy comes in many forms

Orchard TherapeuticsOriginal source

🇺🇸Sep 3, 2020Researchcidrap.umn.eduTier 2 · Direct publisher

News Scan for Sep 02, 2020

CIDRAPOriginal source

🇺🇰Sep 1, 2020Industryorchard-tx.comTier 1 · Company source

Celebrating Orchard’s 5 Year Anniversary

Orchard TherapeuticsOriginal source

🇨🇦Sep 1, 2020Researchucalgary.caTier 2 · Direct publisher

The 2020 Cy Frank Legacy Lecture

University of CalgaryOriginal source

🌍Aug 25, 2020Industryomniab.comTier 1 · Company source

Ligand OmniAb Partner Immunovant Announced Positive Topline Results from Multicenter, Placebo-Controlled Phase 2a Trial of IMVT-1401 in Myasthenia Gravis

OmniAbOriginal source

🇨🇦Aug 25, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

PMPRB research fact checker

Innovative Medicines CanadaOriginal source

🇨🇦Aug 12, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

Innovative Medicines Canada commits to support Canada’s economic recovery while protecting Canadians’ health and well-being

Innovative Medicines CanadaOriginal source

🇺🇸Aug 8, 2020Industrynurabio.comTier 1 · Company source

Nura Bio Announces publication of “Structural and Mechanistic Regulation of the Prodegenerative NAD Hydrolase SARM1” in CELL REPORTS | Nura Bio™

Nura BioOriginal source

🌍Aug 7, 2020Industryomniab.comTier 1 · Company source

CStone Announces That OmniAb-derived CS1001 (Anti-PD-L1) Phase 3 Trial Met the Primary Endpoint as First-Line Treatment in Stage IV Squamous and Non-squamous Non-Small Cell Lung Cancer and Announces Plans to Submit a New Drug Application

OmniAbOriginal source

🇨🇦Aug 6, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

Meet the Experts: Dr. Doron Sagman

Innovative Medicines CanadaOriginal source

🇺🇰Jul 24, 2020Industryorchard-tx.comTier 1 · Company source

Next-Generation Gene Therapy Manufacturing: A Key to Long-Term Growth and Sustainability

Orchard TherapeuticsOriginal source

🇧🇪Jul 10, 2020Regulatoryfamhp.beTier 1 · Regulatory source

Coronavirus and the fight led by the FAMHP: the FAMHP carries out hundreds of controls and inspections to ensure the compliance and safety of medicines and health products

FAMHP (Belgium)Original source

🌍Jul 8, 2020Mediasothema.comTier 2 · Direct publisher

Résultat du vote par résolution Assemblée Générale Ordinaire du 29 juin 2020

Sothema MoroccoOriginal source

🌍Jul 3, 2020Mediasothema.comTier 2 · Direct publisher

Assemblée Générale Ordinaire des actionnaires, tenue le 29 Juin 2020

Sothema MoroccoOriginal source

🇨🇦Jul 3, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

The Hill Times,Letter to the Editor

Innovative Medicines CanadaOriginal source

🇧🇪Jul 1, 2020Regulatoryfamhp.beTier 1 · Regulatory source

Coronavirus and the fight led by the FAMHP: solutions implemented by the FAMHP in the face of medical equipment shortages

FAMHP (Belgium)Original source

🇧🇷Jun 17, 2020Researchfiocruz.brTier 2 · Direct publisher

Quanto tempo o coronavírus permanece ativo em diferentes superfícies?

Fiocruz NewsOriginal source

🌍Jun 8, 2020Mediasothema.comTier 2 · Direct publisher

Formulaire de vote par correspondance à l’assemblée générale

Sothema MoroccoOriginal source

🌍Jun 8, 2020Mediasothema.comTier 2 · Direct publisher

Conseil d’administration tenu le 26/05/2020

Sothema MoroccoOriginal source

🌍Jun 8, 2020Mediasothema.comTier 2 · Direct publisher

Avis de convoncation de actionnaires

Sothema MoroccoOriginal source

🇩🇰Jun 4, 2020Industryserviersymphogen.comTier 3 · Secondary coverage

Servier completes the acquisition of Symphogen

SymphogenOriginal source

🇨🇦Jun 4, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

Meet the experts: Dr. Alex Romanovschi

Innovative Medicines CanadaOriginal source

🇨🇦May 23, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

IMC local initiatives

Innovative Medicines CanadaOriginal source

🇬🇧May 22, 2020Researchhdruk.ac.ukTier 2 · Direct publisher

129096 2

Health Data Research UKOriginal source

🇬🇧May 22, 2020Researchhdruk.ac.ukTier 2 · Direct publisher

129094 2

Health Data Research UKOriginal source

🇨🇦May 21, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

Meet the experts: Vatche Bartekian

Innovative Medicines CanadaOriginal source

🇨🇦May 14, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

Meet the experts: Dion Neame

Innovative Medicines CanadaOriginal source

🇩🇰May 12, 2020Industryserviersymphogen.comTier 3 · Secondary coverage

Symphogen to pursue COVID-19 antibody therapy in a collaboration with Aarhus University

SymphogenOriginal source

🇨🇦May 12, 2020Mediainnovativemedicines.caTier 2 · Direct publisher

IMC welcomes federal Industry Strategy Council and looks forward to helping promote innovation, economic inclusion and growth

Innovative Medicines CanadaOriginal source

🇧🇪May 7, 2020Regulatoryfamhp.beTier 1 · Regulatory source

Coronavirus: new version of Belgian directive for management of clinical trials during coronavirus pandemic

FAMHP (Belgium)Original source

🌍May 7, 2020Industryguerbet.comTier 1 · Company source

Guerbet high in the Gaïa Index for the 2nd year running

GuerbetOriginal source

🌍May 7, 2020Industryguerbet.comTier 1 · Company source

Guerbet en bonne position dans le Gaïa Index 2019 pour la 2ème année consécutive

GuerbetOriginal source

🇬🇧Apr 24, 2020Researchhdruk.ac.ukTier 2 · Direct publisher

MyEyeSite: creating a patient-owned repository of inherited retinal disease data

Health Data Research UKOriginal source

🇩🇰Apr 3, 2020Industryserviersymphogen.comTier 3 · Secondary coverage

Servier underskriver endelig aftale om at erhverve Symphogen, en førende antistof discovery virksomhed, for at styrke Serviers kapacitet inden for antistoffer samt dets forskning og udvikling

SymphogenOriginal source

🇩🇰Apr 3, 2020Industryserviersymphogen.comTier 3 · Secondary coverage

Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline

SymphogenOriginal source

🇺🇸Apr 3, 2020Researchcidrap.umn.eduTier 2 · Direct publisher

News Scan for Apr 02, 2020

CIDRAPOriginal source

🇺🇸Apr 3, 2020Researchcidrap.umn.eduTier 2 · Direct publisher

Stewardship / Resistance Scan for Apr 02, 2020

CIDRAPOriginal source

🇧🇪Jan 15, 2020Regulatoryfamhp.beTier 1 · Regulatory source

Pilot project on simultaneous national scientific advice starts 1 February 2020

FAMHP (Belgium)Original source

🇺🇸Jan 9, 2020CDMOnoramco.comTier 2 · Direct publisher

Meet us at DCAT Week

NoramcoOriginal source

🌍Nov 21, 2019Industryan2therapeutics.comTier 1 · Company source

AN2 Therapeutics Launches with $12 Million in Series A

AN2 TherapeuticsOriginal source

🌍Oct 8, 2019Industryemzorpharma.comTier 1 · Company source

Emzor Wellocracy Radio Show with Pharm Tosin Oguntoye

Emzor PharmaceuticalOriginal source

🌍Oct 8, 2019Industryemzorpharma.comTier 1 · Company source

Emzor Wellocracy Radio Show with Pharm Funmbi Okoya

Emzor PharmaceuticalOriginal source

🌍Oct 8, 2019Industryemzorpharma.comTier 1 · Company source

Emzor Wellocracy Radio Show with Pharm Kehinde Adepoju

Emzor PharmaceuticalOriginal source

🌍Oct 8, 2019Industryemzorpharma.comTier 1 · Company source

Emzor Wellocracy Radio Show with Pharm Muyiwa Olagunju

Emzor PharmaceuticalOriginal source

🇺🇸Aug 31, 2019Researchcidrap.umn.eduTier 2 · Direct publisher

Stewardship / Resistance Scan for Aug 30, 2019

CIDRAPOriginal source

🇺🇸Aug 23, 2019CROflorencehc.comTier 2 · Direct publisher

Why Remote Clinical Trial Monitoring is the New Standard

Florence HealthcareOriginal source

🌍Aug 13, 2019Industryir.cyclerion.comTier 1 · Company source

Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months

Cyclerion TherapeuticsOriginal source

🇺🇸Jul 29, 2019CROflorencehc.comTier 2 · Direct publisher

Overcoming Four Common Challenges in Multicenter Research

Florence HealthcareOriginal source

🌍Jul 15, 2019Industrycervomed.comTier 1 · Company source

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies - CervoMed

CervoMedOriginal source

🌍Jul 10, 2019Industrycervomed.comTier 1 · Company source

EIP Pharma Appoints Noel Donnelly as CFO - CervoMed

CervoMedOriginal source

🌍Jul 10, 2019Industrycervomed.comTier 1 · Company source

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Huntington's Disease - CervoMed

CervoMedOriginal source

🇺🇸Jul 10, 2019CROflorencehc.comTier 2 · Direct publisher

Integrating the eTMF and eISF: Why and Why Now?

Florence HealthcareOriginal source

🌍Jun 27, 2019Industrycervomed.comTier 1 · Company source

EIP Pharma to Host KOL Breakfast Briefing on Potential of Neflamapimod in Alzheimer's Disease and Dementia with Lewy Bodies - CervoMed

CervoMedOriginal source